• S&P 500: 1,351.95
  • Change: 0.00%
$13.17 0.00 (0%)
2/9/2012 4:00 PM

Elan Corp, plc (ADR) (NYSE:ELN)

CAPS Rating: 4 out of 5

The Company's Biopharmaceuticals unit is engaged in research, development and commercial activities and its EDT unit focuses on product development, scale-up and manufacturing to address drug optimization challenges of the pharmaceutical industry.

Current Price $13.17 Mkt Cap $7.73B
Open $0.00 P/E Ratio 0.00
Prev. Close $13.17 Div. (Yield) N/A (N/A)
Daily Range $13.00 - $13.61 Volume 800
52-Wk Range $6.10 - $14.40 Avg. Daily Vol. 0

News & Discussion Boards

Caps

How do you think ELN will perform against the market?

You must Sign in to MSN Caps before you can make a call.

All Players

904 Outperform
72 Underperform
 

All-Star Players

171 Outperform
13 Underperform
 

Wall Street

4 Outperform
4 Underperform
 

Top ELN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

rainmaker59 (70.72)
Submitted November 12, 2009

Rulebreaker pick of Jan. 2009. All debt is related to massive R&D expenses. Leading edge of RX for Crohn's, MS and Alzheimer's.

1 Comment | Reply | Report this Post

michjksn (< 20)
Submitted February 27, 2009

Historically poorly run company. One product which causes death all too often/terrible press. No products on horizon, including Bap, worth anything other than being money pits for underachievement. What R&D there was, has been all but killed off due… More

Add Comment | Reply | Report this Post
ELN VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about ELN.

Recs

0
Member Avatar TMFCop (91.95) Submitted: 1/21/2012 8:42:09 AM : Outperform Start Price: $13.23 ELN Score: -3.38

New labeling and new tests for PML from Quest Diagnostics should open up even more markets -- and sales -- to Tysabri.

Report this Post Add Comment | Reply | Permalink

Recs

0
Member Avatar Coralreefer1 (28.08) Submitted: 10/30/2011 4:04:18 AM : Outperform Start Price: $11.93 ELN Score: +3.95

ELN swings to profits: Tysabri sales up 25%

Report this Post Add Comment | Reply | Permalink

Recs

0
Member Avatar CWKnob2 (< 20) Submitted: 5/18/2011 1:43:17 PM : Outperform Start Price: $8.68 ELN Score: +51.03

+The recent sale of the Micro crystals business shows me they have the cash flow from Tysrabi to finance their new Alzheimer's offering.

Report this Post Add Comment | Reply | Permalink
View All 197 Pitches »

Leaderboard

Find the members with the highest scoring picks in ELN.

Score Leader

BrianMotleyFool

BrianMotleyFool (97.88) Score: +202.52

The Score Leader is the player with the highest score across all their picks in ELN.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		Index
Gain 		Score Commentary
footdoc111 < 20 9/1/2010 Outperform 5Y $4.42 +197.96% +25.11% +172.85 0 Comment
StudlyDoRight < 20 9/2/2010 Outperform 5Y $4.49 +193.32% +24.43% +168.88 0 Comment
LowPoints < 20 6/29/2010 Outperform 5Y $4.51 +192.02% +27.67% +164.34 0 Comment
ElPotrillo < 20 9/13/2010 Outperform 5Y $4.63 +184.45% +20.23% +164.21 0 Comment
062110 < 20 6/24/2010 Outperform 5Y $4.66 +182.62% +24.54% +158.08 0 Comment
cjo103 < 20 7/30/2010 Outperform 1Y $4.67 +182.01% +23.99% +158.02 0 Comment
TradeFields < 20 7/29/2010 Outperform 5Y $4.76 +176.68% +21.38% +155.30 0 Comment
SINOHAN < 20 6/22/2010 Outperform 5Y $4.80 +174.38% +21.50% +152.88 0 Comment
6287210 < 20 6/28/2010 Outperform 5Y $4.80 +174.38% +25.30% +149.08 0 Comment
golfcoach59 < 20 7/2/2010 Outperform 5Y $4.72 +179.03% +31.28% +147.75 0 Comment
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackZacks 70.75 12/5/2011 Underperform 3M $11.35 +16.04% +7.24% -8.79 1 Comment
TrackUltraLong 88.71 11/11/2011 Underperform NS $11.14 +18.22% +7.57% -10.65 1 Comment
TrackZacks 70.75 7/29/2011 Underperform 3M $11.06 +4.52% -5.67% -10.19 11/1/2011 @ $11.56 1 Comment
TrackRBCCapMkts 93.26 4/7/2011 Outperform NS $7.80 +68.85% +1.45% +67.39 0 Comment
TrackUBS 93.25 4/22/2010 Underperform NS $7.34 +79.43% +12.98% -66.45 0 Comment
TrackUBS 93.25 7/20/2009 Outperform NS $7.65 -35.03% +11.10% -46.13 10/29/2009 @ $4.97 0 Comment
TrackRBCCapMkts 93.26 1/22/2009 Underperform NS $7.07 -8.63% +54.70% +63.33 1/6/2011 @ $6.46 0 Comment
TrackCanaccord 90.33 1/14/2009 Outperform NS $8.92 +47.65% +58.82% -11.18 0 Comment
TrackBreanMurray 69.41 7/11/2008 Underperform NS $34.91 -78.23% -2.26% +75.97 4/21/2010 @ $7.60 0 Comment
TrackPiperJaff 88.99 7/11/2008 Underperform NS $34.91 -81.72% -32.26% +49.47 4/3/2009 @ $6.38 0 Comment
trackmerriman 70.87 6/11/2008 Outperform NS $26.33 -49.98% +2.87% -52.85 0 Comment
TrackCarisandCo 88.55 5/15/2008 Underperform NS $27.10 -74.69% -38.11% +36.58 10/24/2008 @ $6.86 0 Comment
TrackCanaccord 90.33 3/26/2008 Underperform NS $20.78 -62.66% -35.50% +27.15 1/13/2009 @ $7.76 0 Comment
TrackCreditSuiss 93.26 3/5/2008 Outperform NS $21.93 -49.20% -5.94% -43.26 8/4/2008 @ $11.14 0 Comment
TrackLehmanBros 88.86 2/14/2008 Underperform NS $25.51 -54.68% -6.57% +48.11 8/6/2008 @ $11.56 0 Comment
TrackFBRCapitalM 84.41 10/2/2007 Underperform NS $21.19 +73.76% -18.96% -92.72 7/10/2008 @ $36.82 0 Comment
TrackEdwardOwens 98.63 9/30/2007 Outperform NS $21.04 -37.40% -7.05% -30.35 5 Comments
TrackJimCramer 78.02 8/28/2007 Underperform 3W $18.86 -30.17% -0.86% +29.31 0 Comment
TrackJimCramer 78.02 6/18/2007 Outperform 3W $21.68 -13.01% -6.00% -7.01 8/29/2007 @ $18.86 0 Comment
TrackUBS 93.25 8/14/2006 Underperform NS $14.52 +148.14% -2.27% -150.41 7/10/2008 @ $36.03 0 Comment
TrackJimCramer 78.02 3/2/2006 Underperform 3W $12.81 +69.24% +18.80% -50.44 6/19/2007 @ $21.68 0 Comment

Featured Broker Partners